NCT05323370View on ClinicalTrials.gov

Lymphangioleiomyomatosis, a Study on Cathepsin K

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

October 30, 2022

Study Completion Date

October 30, 2022

Conditions
LymphangioleiomyomatosisTuberous Sclerosis Complex
Interventions
OTHER

24h urine

Urine samples will be collected at home over 24 hours

OTHER

urine sample

A urine sample of 20cc will be collected

Trial Locations (1)

37044

University hospital, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER